Pivot Bio LLC Series B

### Executive Summary Pivot Bio LLC raised $77.9M in a Series B Reg D private placement, first sale April 2025. Backed by prominent investors Andreessen Horowitz and Y Combinator, the filing indicates strong institutional confidence despite an unusual industry classification. ### Investor Edge Watch for a Form D/A amendment, which could reveal additional investors or a larger round, signaling continued momentum or terms changes. ### Sector capital positioning The $77.9M raise in Advanced Materials / Space Logistics suggests growing private capital appetite in these sectors, though the company name 'Pivot Bio' implies biotech—potential sector misclassification should be monitored. ### Convergence Signals No explicit public signals (patents, contracts, legislation) are evident from this filing alone. ### Key Takeaways - $77.9M raised in Series B private placement. - Andreessen Horowitz and Y Combinator listed as related persons (likely directors/investors). - Industry classified as Advanced Materials / Space Logistics, a potential mismatch with company name (Pivot Bio). ### Risk Indicators & Flags Industry classification (Advanced Materials / Space Logistics) appears inconsistent with the company name 'Pivot Bio', which suggests biotechnology. This could indicate a data entry error or a strategic pivot; further verification is warranted. No D/A amendments yet, so round may still be open. ### Verification & References Verified via SEC EDGAR filing (Accession: 0001702600-24-001031). Company name: Pivot Bio LLC Series B; Form D; Capital: $77.9M; First sale: 2025-04-01; Related persons: Andreessen Horowitz, Y Combinator.